Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Novo Nordisk reports positive results from SUSTAIN 9 trial

Oral semaglutide in a tablet intended for treatment of adults with type 2 diabetes. Credit: Novo Nordisk A/S.



  • Novo Nordisk reports positive results from SUSTAIN 9 trial

Go Top